Call Us

ARTICLES

Arthrosamid®’s story started two decades ago. The brainchild of the team at Contura, the product had been in human use for various indications since 2000, and a favourable safety profile had already been established.

PATIENTS GAIN ACCESS TO INNOVATIVE NEW PROCEDURE FOR TREATING KNEE OSTEOARTHRITIS AS HCA UK PARTNERS WITH CONTURA ORTHOPAEDICS

London, September 2022; Contura Orthopaedics Ltd is pleased to announce that a major hospital group has signed up to Arthrosamid, allowing clinicians to offer this novel procedure to its patients in London and across the UK.

musculoskeletal disorders in addition to sporting injuries and complaints at its state-of-the-art facility located on Tottenham Court Road in Central London. The treatment will be rolled out across other facilities across the HCA Healthcare UK group in the coming months.

Arthrosamid is a polyacrylamide hydrogel first developed by Contura International Ltd. It is a long-lasting intra-articular injection approved in Europe for the treatment of knee OA. The treatment has the potential to change the present care pathway for managing OA, which affects approximately

Unravelling the ICD-10 Coding Challenges: Primary Osteoarthritis of the Left Knee and Its Clinical Implications

Primary osteoarthritis of the left knee is a prevalent degenerative joint disease causing pain, stiffness, and reduced mobility, especially in older adults. Accurate clinical documentation and precise ICD-10 coding, such as M17.12 for this condition, are crucial for effective patient care, treatment planning, and health data accuracy. This article highlights the importance of considering joint laterality, associated features like subchondral cysts, genetic factors, and fall risk in diagnosis and management. Advances in genetics and therapies, including diacerein treatment, underscore evolving care approaches. Comprehensive and specific coding enhances healthcare resource allocation and supports research, emphasizing continuous education for clinicians and coders to improve outcomes for patients with primary knee osteoarthritis.

Read More »

Decoding the Choice: A Step-by-Step Patient Guide to Selecting the Best Knee Gel Injection for Osteoarthritis Relief

Explore comprehensive insights into knee gel injections for osteoarthritis, including hyaluronic acid, polyacrylamide hydrogel (PAAG), and platelet-rich plasma (PRP). This guide compares efficacy, treatment schedules, and suitability based on severity, age, and lifestyle. Discover how PAAG offers longer-lasting relief with a single injection, while HA and PRP provide alternatives suited to different patient needs. Supported by recent studies, understand the benefits, risks, and how to make informed decisions with your healthcare provider for personalized osteoarthritis management.

Read More »